

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | urate metabolic process (GO:0046415) | 8.30198651 |
| 2 | drug transmembrane transport (GO:0006855) | 8.19823975 |
| 3 | aminoglycoside antibiotic metabolic process (GO:0030647) | 7.92660188 |
| 4 | drug transport (GO:0015893) | 6.90521140 |
| 5 | lysine metabolic process (GO:0006553) | 6.82404846 |
| 6 | lysine catabolic process (GO:0006554) | 6.82404846 |
| 7 | organic cation transport (GO:0015695) | 6.49247305 |
| 8 | phosphate ion transport (GO:0006817) | 6.46515894 |
| 9 | glyoxylate metabolic process (GO:0046487) | 5.90276321 |
| 10 | glomerular basement membrane development (GO:0032836) | 5.80650694 |
| 11 | glomerular visceral epithelial cell development (GO:0072015) | 5.54730882 |
| 12 | drug catabolic process (GO:0042737) | 5.49008778 |
| 13 | exogenous drug catabolic process (GO:0042738) | 5.47454159 |
| 14 | quaternary ammonium group transport (GO:0015697) | 5.43828580 |
| 15 | phosphate ion transmembrane transport (GO:0035435) | 5.28342491 |
| 16 | cysteine metabolic process (GO:0006534) | 5.20956849 |
| 17 | response to mercury ion (GO:0046689) | 5.16270944 |
| 18 | excretion (GO:0007588) | 5.14714687 |
| 19 | glomerular epithelial cell development (GO:0072310) | 4.85250570 |
| 20 | tricarboxylic acid metabolic process (GO:0072350) | 4.75766973 |
| 21 | renal absorption (GO:0070293) | 4.61938310 |
| 22 | vitamin D metabolic process (GO:0042359) | 4.58548543 |
| 23 | short-chain fatty acid metabolic process (GO:0046459) | 4.42113691 |
| 24 | aspartate family amino acid catabolic process (GO:0009068) | 4.39657224 |
| 25 | metanephric tubule development (GO:0072170) | 4.31871664 |
| 26 | metanephric nephron tubule development (GO:0072234) | 4.31871664 |
| 27 | L-phenylalanine metabolic process (GO:0006558) | 4.26647795 |
| 28 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.26647795 |
| 29 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 4.22920858 |
| 30 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.16385335 |
| 31 | L-phenylalanine catabolic process (GO:0006559) | 4.16385335 |
| 32 | nonribosomal peptide biosynthetic process (GO:0019184) | 4.14791851 |
| 33 | phosphate ion homeostasis (GO:0055062) | 4.08683593 |
| 34 | trivalent inorganic anion homeostasis (GO:0072506) | 4.08683593 |
| 35 | aromatic amino acid family catabolic process (GO:0009074) | 4.08638785 |
| 36 | branched-chain amino acid metabolic process (GO:0009081) | 4.07314648 |
| 37 | metanephric epithelium development (GO:0072207) | 4.06642635 |
| 38 | homocysteine metabolic process (GO:0050667) | 4.01681483 |
| 39 | metanephric nephron epithelium development (GO:0072243) | 4.01660067 |
| 40 | proline metabolic process (GO:0006560) | 3.97749214 |
| 41 | indole-containing compound catabolic process (GO:0042436) | 3.96895933 |
| 42 | indolalkylamine catabolic process (GO:0046218) | 3.96895933 |
| 43 | tryptophan catabolic process (GO:0006569) | 3.96895933 |
| 44 | carnitine transport (GO:0015879) | 3.96297613 |
| 45 | amino-acid betaine transport (GO:0015838) | 3.96297613 |
| 46 | serine family amino acid catabolic process (GO:0009071) | 3.96133640 |
| 47 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.95470545 |
| 48 | complement activation, alternative pathway (GO:0006957) | 3.95170119 |
| 49 | cellular response to vitamin D (GO:0071305) | 3.93178354 |
| 50 | cellular modified amino acid catabolic process (GO:0042219) | 3.86387307 |
| 51 | valine metabolic process (GO:0006573) | 3.82409414 |
| 52 | cardiac myofibril assembly (GO:0055003) | 3.76253933 |
| 53 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.73879679 |
| 54 | tryptophan metabolic process (GO:0006568) | 3.73050940 |
| 55 | ethanol oxidation (GO:0006069) | 3.72739178 |
| 56 | glutathione biosynthetic process (GO:0006750) | 3.70104819 |
| 57 | 2-oxoglutarate metabolic process (GO:0006103) | 3.66093737 |
| 58 | response to phenylpropanoid (GO:0080184) | 3.64852139 |
| 59 | toxin transport (GO:1901998) | 3.63713389 |
| 60 | modified amino acid transport (GO:0072337) | 3.62665221 |
| 61 | serine family amino acid metabolic process (GO:0009069) | 3.62528842 |
| 62 | amino-acid betaine metabolic process (GO:0006577) | 3.61671539 |
| 63 | keratan sulfate catabolic process (GO:0042340) | 3.54527550 |
| 64 | response to parathyroid hormone (GO:0071107) | 3.53867249 |
| 65 | uronic acid metabolic process (GO:0006063) | 3.51813597 |
| 66 | glucuronate metabolic process (GO:0019585) | 3.51813597 |
| 67 | fatty acid beta-oxidation (GO:0006635) | 3.51516010 |
| 68 | glucocorticoid biosynthetic process (GO:0006704) | 3.45309468 |
| 69 | cellular glucuronidation (GO:0052695) | 3.42081346 |
| 70 | epoxygenase P450 pathway (GO:0019373) | 3.41777848 |
| 71 | 4-hydroxyproline metabolic process (GO:0019471) | 3.41328687 |
| 72 | acetyl-CoA metabolic process (GO:0006084) | 3.38904469 |
| 73 | nephron tubule development (GO:0072080) | 3.38094262 |
| 74 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.37488874 |
| 75 | cell communication by electrical coupling (GO:0010644) | 3.37183023 |
| 76 | branched-chain amino acid catabolic process (GO:0009083) | 3.36869268 |
| 77 | regulation of cardioblast differentiation (GO:0051890) | 3.36401365 |
| 78 | glomerulus development (GO:0032835) | 3.31136189 |
| 79 | nephron tubule morphogenesis (GO:0072078) | 3.29958302 |
| 80 | nephron epithelium morphogenesis (GO:0072088) | 3.29958302 |
| 81 | fatty acid oxidation (GO:0019395) | 3.28819640 |
| 82 | myofibril assembly (GO:0030239) | 3.26924361 |
| 83 | fructose metabolic process (GO:0006000) | 3.26470766 |
| 84 | regulation of protein activation cascade (GO:2000257) | 3.25661032 |
| 85 | response to magnesium ion (GO:0032026) | 3.25354845 |
| 86 | cellular response to vitamin (GO:0071295) | 3.23992841 |
| 87 | regulation of complement activation (GO:0030449) | 3.22055425 |
| 88 | glycoside metabolic process (GO:0016137) | 3.21735946 |
| 89 | polyol transport (GO:0015791) | 3.21471506 |
| 90 | lipid oxidation (GO:0034440) | 3.21328565 |
| 91 | cellular ketone body metabolic process (GO:0046950) | 3.19704069 |
| 92 | carnitine metabolic process (GO:0009437) | 3.14234115 |
| 93 | cell migration involved in heart development (GO:0060973) | 3.13689825 |
| 94 | omega-hydroxylase P450 pathway (GO:0097267) | 3.13041836 |
| 95 | response to lead ion (GO:0010288) | 3.12722993 |
| 96 | chondrocyte development (GO:0002063) | 3.11374051 |
| 97 | collagen fibril organization (GO:0030199) | 3.10320527 |
| 98 | cellular amino acid catabolic process (GO:0009063) | 3.08730188 |
| 99 | peptide catabolic process (GO:0043171) | 3.05297368 |
| 100 | alpha-amino acid catabolic process (GO:1901606) | 3.03823275 |
| 101 | kynurenine metabolic process (GO:0070189) | 3.02983824 |
| 102 | renal tubule morphogenesis (GO:0061333) | 3.02726458 |
| 103 | glutamate metabolic process (GO:0006536) | 3.02408145 |
| 104 | vitamin transport (GO:0051180) | 3.02151186 |
| 105 | NADH metabolic process (GO:0006734) | 3.00919981 |
| 106 | regulation of plasminogen activation (GO:0010755) | 3.00381255 |
| 107 | nephron epithelium development (GO:0072009) | 2.99327558 |
| 108 | response to growth hormone (GO:0060416) | 2.98811988 |
| 109 | outflow tract septum morphogenesis (GO:0003148) | 2.97298685 |
| 110 | renal tubule development (GO:0061326) | 2.93864988 |
| 111 | aromatic amino acid family metabolic process (GO:0009072) | 2.91344214 |
| 112 | sulfur amino acid catabolic process (GO:0000098) | 2.90675196 |
| 113 | cardiac chamber formation (GO:0003207) | 2.90462421 |
| 114 | sodium-independent organic anion transport (GO:0043252) | 2.89576834 |
| 115 | response to water (GO:0009415) | 2.88373788 |
| 116 | peptide biosynthetic process (GO:0043043) | 2.88222765 |
| 117 | cellular response to epinephrine stimulus (GO:0071872) | 2.87855562 |
| 118 | serine family amino acid biosynthetic process (GO:0009070) | 2.87715803 |
| 119 | drug metabolic process (GO:0017144) | 2.87367568 |
| 120 | cardiac muscle contraction (GO:0060048) | 2.86460328 |
| 121 | cellular sodium ion homeostasis (GO:0006883) | 2.82523134 |
| 122 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.81190752 |
| 123 | negative regulation of sterol transport (GO:0032372) | 2.79617313 |
| 124 | negative regulation of cholesterol transport (GO:0032375) | 2.79617313 |
| 125 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.79062833 |
| 126 | ethanol metabolic process (GO:0006067) | 2.76967460 |
| 127 | virion attachment to host cell (GO:0019062) | 2.71922823 |
| 128 | adhesion of symbiont to host cell (GO:0044650) | 2.71922823 |
| 129 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.71631287 |
| 130 | cell volume homeostasis (GO:0006884) | 2.70035836 |
| 131 | negative regulation of catenin import into nucleus (GO:0035414) | 2.69141424 |
| 132 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 2.68953579 |
| 133 | sodium ion export (GO:0071436) | 2.68350121 |
| 134 | sarcomere organization (GO:0045214) | 2.63934334 |
| 135 | response to epinephrine (GO:0071871) | 2.62580629 |
| 136 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.61767388 |
| 137 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.61011162 |
| 138 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.60770394 |
| 139 | adhesion of symbiont to host (GO:0044406) | 2.60195380 |
| 140 | cellular response to cadmium ion (GO:0071276) | 2.59106978 |
| 141 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.57948700 |
| 142 | regulation of actin filament-based movement (GO:1903115) | 2.57774114 |
| 143 | cGMP-mediated signaling (GO:0019934) | 2.57325046 |
| 144 | cell communication involved in cardiac conduction (GO:0086065) | 2.56939461 |
| 145 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 2.56443465 |
| 146 | cardiac muscle hypertrophy (GO:0003300) | 2.55662086 |
| 147 | opsonization (GO:0008228) | 2.49826490 |
| 148 | response to dietary excess (GO:0002021) | 2.48671034 |
| 149 | glucocorticoid metabolic process (GO:0008211) | 2.47573672 |
| 150 | cardiac ventricle formation (GO:0003211) | 2.46157189 |
| 151 | cardiac muscle tissue morphogenesis (GO:0055008) | 2.42413911 |
| 152 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.42275823 |
| 153 | striated muscle hypertrophy (GO:0014897) | 2.40829715 |
| 154 | cellular response to catecholamine stimulus (GO:0071870) | 2.40490107 |
| 155 | cellular response to monoamine stimulus (GO:0071868) | 2.40490107 |
| 156 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.36754470 |
| 157 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.36754470 |
| 158 | muscle filament sliding (GO:0030049) | 2.35769319 |
| 159 | actin-myosin filament sliding (GO:0033275) | 2.35769319 |
| 160 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.34946886 |
| 161 | blood coagulation, intrinsic pathway (GO:0007597) | 2.33344140 |
| 162 | oxaloacetate metabolic process (GO:0006107) | 2.32971588 |
| 163 | atrial septum morphogenesis (GO:0060413) | 2.32691757 |
| 164 | myelination in peripheral nervous system (GO:0022011) | 2.32389955 |
| 165 | peripheral nervous system axon ensheathment (GO:0032292) | 2.32389955 |
| 166 | regulation of the force of heart contraction (GO:0002026) | 2.31516041 |
| 167 | urea metabolic process (GO:0019627) | 2.31301550 |
| 168 | cardiac muscle adaptation (GO:0014887) | 2.30541381 |
| 169 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.30541381 |
| 170 | muscle hypertrophy in response to stress (GO:0003299) | 2.30541381 |
| 171 | regulation of female receptivity (GO:0045924) | 2.30029102 |
| 172 | sodium ion homeostasis (GO:0055078) | 2.29711281 |
| 173 | fatty acid homeostasis (GO:0055089) | 2.28161186 |
| 174 | acylglycerol homeostasis (GO:0055090) | 2.26985427 |
| 175 | triglyceride homeostasis (GO:0070328) | 2.26985427 |
| 176 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.26591241 |
| 177 | muscle tissue morphogenesis (GO:0060415) | 2.25208182 |
| 178 | regulation of fibrinolysis (GO:0051917) | 2.23679044 |
| 179 | protein carboxylation (GO:0018214) | 2.23070041 |
| 180 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.23070041 |
| 181 | triglyceride catabolic process (GO:0019433) | 2.22570372 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 5.68221789 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.40459262 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.10708117 |
| 4 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 3.94837003 |
| 5 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.85063310 |
| 6 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.71108143 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.63049265 |
| 8 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.41955995 |
| 9 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.20827346 |
| 10 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.07121334 |
| 11 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.69890811 |
| 12 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.63961107 |
| 13 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.63663545 |
| 14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.50229235 |
| 15 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.44396211 |
| 16 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.26830883 |
| 17 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.23741533 |
| 18 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.19711344 |
| 19 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.06611500 |
| 20 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.03895989 |
| 21 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.03441252 |
| 22 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.98783297 |
| 23 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.96605079 |
| 24 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.93479718 |
| 25 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.89936486 |
| 26 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.89112253 |
| 27 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.88825495 |
| 28 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.88061469 |
| 29 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.83149636 |
| 30 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.78048725 |
| 31 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.77627707 |
| 32 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.76513662 |
| 33 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.70451770 |
| 34 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.67111052 |
| 35 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.61275239 |
| 36 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.61003122 |
| 37 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.57782147 |
| 38 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.55463520 |
| 39 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.49239541 |
| 40 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.48855534 |
| 41 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.48192303 |
| 42 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.47489786 |
| 43 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.47437783 |
| 44 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.45930783 |
| 45 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.43756483 |
| 46 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.43089828 |
| 47 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.42389422 |
| 48 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.36936266 |
| 49 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.35138367 |
| 50 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.34968994 |
| 51 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.34968994 |
| 52 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.34660448 |
| 53 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.34425744 |
| 54 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.30589202 |
| 55 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.28837288 |
| 56 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.28160656 |
| 57 | CJUN_26792858_Chip-Seq_BT549_Human | 1.25058285 |
| 58 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.24701308 |
| 59 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.24309628 |
| 60 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.24309628 |
| 61 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.22755545 |
| 62 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.21966053 |
| 63 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.21072313 |
| 64 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.20911208 |
| 65 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.20887263 |
| 66 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.20800657 |
| 67 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.20398245 |
| 68 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.19740353 |
| 69 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.18453461 |
| 70 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.14083324 |
| 71 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.13527690 |
| 72 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.13213857 |
| 73 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.12620238 |
| 74 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.12480837 |
| 75 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.11879190 |
| 76 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.11618071 |
| 77 | RXR_22108803_ChIP-Seq_LS180_Human | 1.11555632 |
| 78 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.07920927 |
| 79 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.07368217 |
| 80 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.07116570 |
| 81 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.06198172 |
| 82 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.05844836 |
| 83 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.05703954 |
| 84 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.05630251 |
| 85 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.03594869 |
| 86 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.02671100 |
| 87 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.02502442 |
| 88 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.01791072 |
| 89 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.01473051 |
| 90 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.00241858 |
| 91 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.99279557 |
| 92 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.98826731 |
| 93 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.97774207 |
| 94 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.97618166 |
| 95 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.97530358 |
| 96 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.96295022 |
| 97 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.95963963 |
| 98 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.95416762 |
| 99 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.94946886 |
| 100 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.94305896 |
| 101 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.94176847 |
| 102 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.93072685 |
| 103 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.92912065 |
| 104 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.91608761 |
| 105 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.90183533 |
| 106 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.89728245 |
| 107 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.89444301 |
| 108 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.87892939 |
| 109 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.87353186 |
| 110 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.87034634 |
| 111 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 0.86977992 |
| 112 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.86794474 |
| 113 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.86319126 |
| 114 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.86196538 |
| 115 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.85635186 |
| 116 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.85635186 |
| 117 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.85304852 |
| 118 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.84614742 |
| 119 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.84411157 |
| 120 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.84224460 |
| 121 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.84021475 |
| 122 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.83924433 |
| 123 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.83356339 |
| 124 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.83174496 |
| 125 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.83128905 |
| 126 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.82815507 |
| 127 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.82732563 |
| 128 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.82028498 |
| 129 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.81808133 |
| 130 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.81632148 |
| 131 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.80760581 |
| 132 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.79820164 |
| 133 | P68_20966046_ChIP-Seq_HELA_Human | 0.79354081 |
| 134 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.79264435 |
| 135 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.79222970 |
| 136 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.79106788 |
| 137 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.79020611 |
| 138 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.78649088 |
| 139 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.78266786 |
| 140 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.77434917 |
| 141 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.76819589 |
| 142 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.76356414 |
| 143 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.75997285 |
| 144 | ATF3_27146783_Chip-Seq_COLON_Human | 0.75705278 |
| 145 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.75371096 |
| 146 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.74414001 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 6.12537085 |
| 2 | MP0004043_abnormal_pH_regulation | 4.43386694 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 4.15048361 |
| 4 | MP0005332_abnormal_amino_acid | 4.13216203 |
| 5 | MP0004019_abnormal_vitamin_homeostasis | 3.75593209 |
| 6 | MP0009643_abnormal_urine_homeostasis | 3.22121411 |
| 7 | MP0003195_calcinosis | 3.10839629 |
| 8 | MP0004272_abnormal_basement_membrane | 2.98121169 |
| 9 | MP0001958_emphysema | 2.80074436 |
| 10 | MP0005503_abnormal_tendon_morphology | 2.78759363 |
| 11 | MP0002138_abnormal_hepatobiliary_system | 2.66752738 |
| 12 | MP0002136_abnormal_kidney_physiology | 2.61411181 |
| 13 | MP0003283_abnormal_digestive_organ | 2.60945551 |
| 14 | MP0001756_abnormal_urination | 2.54454977 |
| 15 | MP0002837_dystrophic_cardiac_calcinosis | 2.43442284 |
| 16 | * MP0001765_abnormal_ion_homeostasis | 2.43309447 |
| 17 | MP0004859_abnormal_synaptic_plasticity | 2.15716985 |
| 18 | MP0005377_hearing/vestibular/ear_phenot | 2.10172915 |
| 19 | MP0003878_abnormal_ear_physiology | 2.10172915 |
| 20 | MP0004215_abnormal_myocardial_fiber | 2.08116085 |
| 21 | MP0003646_muscle_fatigue | 2.05037595 |
| 22 | MP0009384_cardiac_valve_regurgitation | 1.95664131 |
| 23 | * MP0005636_abnormal_mineral_homeostasis | 1.94999940 |
| 24 | MP0003252_abnormal_bile_duct | 1.94517134 |
| 25 | * MP0002896_abnormal_bone_mineralization | 1.93126055 |
| 26 | MP0008438_abnormal_cutaneous_collagen | 1.92827257 |
| 27 | MP0008875_abnormal_xenobiotic_pharmacok | 1.89089017 |
| 28 | * MP0000163_abnormal_cartilage_morphology | 1.86266584 |
| 29 | MP0004130_abnormal_muscle_cell | 1.83021095 |
| 30 | * MP0002115_abnormal_skeleton_extremities | 1.80375307 |
| 31 | MP0002282_abnormal_trachea_morphology | 1.78400922 |
| 32 | MP0005365_abnormal_bile_salt | 1.78278723 |
| 33 | MP0009250_abnormal_appendicular_skeleto | 1.70103336 |
| 34 | MP0003137_abnormal_impulse_conducting | 1.68911847 |
| 35 | MP0001542_abnormal_bone_strength | 1.68002482 |
| 36 | MP0003879_abnormal_hair_cell | 1.67372046 |
| 37 | MP0005085_abnormal_gallbladder_physiolo | 1.67192887 |
| 38 | MP0002249_abnormal_larynx_morphology | 1.66657227 |
| 39 | MP0005623_abnormal_meninges_morphology | 1.63239345 |
| 40 | MP0002089_abnormal_postnatal_growth/wei | 1.61601321 |
| 41 | MP0005330_cardiomyopathy | 1.57667382 |
| 42 | MP0003705_abnormal_hypodermis_morpholog | 1.55430347 |
| 43 | MP0006138_congestive_heart_failure | 1.52287971 |
| 44 | MP0002933_joint_inflammation | 1.45344961 |
| 45 | MP0004134_abnormal_chest_morphology | 1.43090694 |
| 46 | MP0002971_abnormal_brown_adipose | 1.37089446 |
| 47 | MP0008961_abnormal_basal_metabolism | 1.35133894 |
| 48 | MP0000230_abnormal_systemic_arterial | 1.34645690 |
| 49 | * MP0002113_abnormal_skeleton_development | 1.33840080 |
| 50 | MP0002972_abnormal_cardiac_muscle | 1.29137874 |
| 51 | MP0005666_abnormal_adipose_tissue | 1.29108975 |
| 52 | MP0003942_abnormal_urinary_system | 1.28684866 |
| 53 | MP0002135_abnormal_kidney_morphology | 1.26238588 |
| 54 | MP0000566_synostosis | 1.24499586 |
| 55 | MP0004087_abnormal_muscle_fiber | 1.24468787 |
| 56 | MP0010630_abnormal_cardiac_muscle | 1.23849676 |
| 57 | MP0005084_abnormal_gallbladder_morpholo | 1.22180665 |
| 58 | MP0005275_abnormal_skin_tensile | 1.21597363 |
| 59 | MP0005385_cardiovascular_system_phenoty | 1.18436518 |
| 60 | MP0001544_abnormal_cardiovascular_syste | 1.18436518 |
| 61 | MP0009780_abnormal_chondrocyte_physiolo | 1.17385897 |
| 62 | MP0003795_abnormal_bone_structure | 1.16721845 |
| 63 | MP0003806_abnormal_nucleotide_metabolis | 1.16438390 |
| 64 | MP0000534_abnormal_ureter_morphology | 1.15884951 |
| 65 | MP0005319_abnormal_enzyme/_coenzyme | 1.15867025 |
| 66 | MP0002108_abnormal_muscle_morphology | 1.15345912 |
| 67 | MP0005058_abnormal_lysosome_morphology | 1.15278819 |
| 68 | MP0002127_abnormal_cardiovascular_syste | 1.14987489 |
| 69 | MP0004085_abnormal_heartbeat | 1.13171260 |
| 70 | MP0000538_abnormal_urinary_bladder | 1.12789913 |
| 71 | MP0005620_abnormal_muscle_contractility | 1.12255952 |
| 72 | MP0003329_amyloid_beta_deposits | 1.10905425 |
| 73 | MP0003690_abnormal_glial_cell | 1.07069794 |
| 74 | MP0010030_abnormal_orbit_morphology | 1.06456459 |
| 75 | MP0003186_abnormal_redox_activity | 1.05252621 |
| 76 | MP0005508_abnormal_skeleton_morphology | 1.02349935 |
| 77 | MP0000751_myopathy | 1.00944170 |
| 78 | MP0004084_abnormal_cardiac_muscle | 1.00572389 |
| 79 | MP0000003_abnormal_adipose_tissue | 0.99132927 |
| 80 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.97907453 |
| 81 | MP0005451_abnormal_body_composition | 0.97090608 |
| 82 | MP0003635_abnormal_synaptic_transmissio | 0.96242575 |
| 83 | MP0001270_distended_abdomen | 0.95918692 |
| 84 | MP0003279_aneurysm | 0.95731743 |
| 85 | MP0005369_muscle_phenotype | 0.95162164 |
| 86 | MP0001177_atelectasis | 0.94982457 |
| 87 | MP0002168_other_aberrant_phenotype | 0.93476336 |
| 88 | MP0005670_abnormal_white_adipose | 0.93197570 |
| 89 | MP0000013_abnormal_adipose_tissue | 0.91238987 |
| 90 | * MP0002998_abnormal_bone_remodeling | 0.90857207 |
| 91 | MP0004185_abnormal_adipocyte_glucose | 0.90841459 |
| 92 | MP0004510_myositis | 0.89395754 |
| 93 | MP0003880_abnormal_central_pattern | 0.88602519 |
| 94 | MP0001486_abnormal_startle_reflex | 0.87600367 |
| 95 | * MP0002109_abnormal_limb_morphology | 0.86833848 |
| 96 | MP0000759_abnormal_skeletal_muscle | 0.85581431 |
| 97 | MP0004270_analgesia | 0.85453160 |
| 98 | MP0009840_abnormal_foam_cell | 0.83279494 |
| 99 | MP0000750_abnormal_muscle_regeneration | 0.83243346 |
| 100 | MP0006054_spinal_hemorrhage | 0.82894279 |
| 101 | MP0000537_abnormal_urethra_morphology | 0.82757244 |
| 102 | MP0002928_abnormal_bile_duct | 0.81965944 |
| 103 | MP0004145_abnormal_muscle_electrophysio | 0.81395726 |
| 104 | MP0003567_abnormal_fetal_cardiomyocyte | 0.81301865 |
| 105 | MP0004885_abnormal_endolymph | 0.80646628 |
| 106 | MP0005595_abnormal_vascular_smooth | 0.79273651 |
| 107 | MP0005535_abnormal_body_temperature | 0.78671111 |
| 108 | MP0000767_abnormal_smooth_muscle | 0.78542154 |
| 109 | MP0000749_muscle_degeneration | 0.78114942 |
| 110 | MP0000462_abnormal_digestive_system | 0.77067720 |
| 111 | MP0009053_abnormal_anal_canal | 0.76052984 |
| 112 | MP0002064_seizures | 0.75729961 |
| 113 | MP0002106_abnormal_muscle_physiology | 0.75177044 |
| 114 | MP0001661_extended_life_span | 0.74923235 |
| 115 | MP0002063_abnormal_learning/memory/cond | 0.73944717 |
| 116 | MP0003941_abnormal_skin_development | 0.73550515 |
| 117 | MP0002932_abnormal_joint_morphology | 0.73165099 |
| 118 | MP0003300_gastrointestinal_ulcer | 0.71466451 |
| 119 | MP0002269_muscular_atrophy | 0.70455644 |
| 120 | MP0009115_abnormal_fat_cell | 0.69298115 |
| 121 | MP0002295_abnormal_pulmonary_circulatio | 0.68901008 |
| 122 | MP0005375_adipose_tissue_phenotype | 0.68668733 |
| 123 | MP0000639_abnormal_adrenal_gland | 0.68008053 |
| 124 | MP0003191_abnormal_cellular_cholesterol | 0.67092064 |
| 125 | MP0002118_abnormal_lipid_homeostasis | 0.66458303 |
| 126 | MP0002876_abnormal_thyroid_physiology | 0.65968959 |
| 127 | MP0003566_abnormal_cell_adhesion | 0.65748153 |
| 128 | MP0001879_abnormal_lymphatic_vessel | 0.65741565 |
| 129 | MP0004858_abnormal_nervous_system | 0.65106028 |
| 130 | MP0005390_skeleton_phenotype | 0.64695760 |
| 131 | MP0001915_intracranial_hemorrhage | 0.64634472 |
| 132 | MP0004484_altered_response_of | 0.64379621 |
| 133 | * MP0002116_abnormal_craniofacial_bone | 0.64027989 |
| 134 | MP0000747_muscle_weakness | 0.63446431 |
| 135 | MP0003123_paternal_imprinting | 0.62835754 |
| 136 | MP0010368_abnormal_lymphatic_system | 0.60506675 |
| 137 | MP0001299_abnormal_eye_distance/ | 0.60432644 |
| 138 | MP0008775_abnormal_heart_ventricle | 0.57829232 |
| 139 | MP0000049_abnormal_middle_ear | 0.57310728 |
| 140 | MP0003385_abnormal_body_wall | 0.56867402 |
| 141 | MP0004036_abnormal_muscle_relaxation | 0.53884944 |
| 142 | MP0009672_abnormal_birth_weight | 0.53811340 |
| 143 | * MP0000432_abnormal_head_morphology | 0.53647717 |
| 144 | MP0003115_abnormal_respiratory_system | 0.53113504 |
| 145 | MP0010329_abnormal_lipoprotein_level | 0.52745979 |
| 146 | MP0003638_abnormal_response/metabolism_ | 0.52049333 |
| 147 | MP0002111_abnormal_tail_morphology | 0.51639252 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased circulating renin level (HP:0000848) | 5.96188184 |
| 2 | Hypokalemic alkalosis (HP:0001949) | 5.58920431 |
| 3 | Metabolic alkalosis (HP:0200114) | 5.32235509 |
| 4 | Gout (HP:0001997) | 5.22687433 |
| 5 | Hypomagnesemia (HP:0002917) | 5.08752900 |
| 6 | Epiphyseal dysplasia (HP:0002656) | 5.06798290 |
| 7 | Polyuria (HP:0000103) | 4.94981291 |
| 8 | Hyperactive renin-angiotensin system (HP:0000841) | 4.84987801 |
| 9 | Complement deficiency (HP:0004431) | 4.82921954 |
| 10 | Abnormal urine output (HP:0012590) | 4.64322816 |
| 11 | Abnormality of chloride homeostasis (HP:0011422) | 4.50802681 |
| 12 | Abnormality of renal excretion (HP:0011036) | 4.37880059 |
| 13 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.32451169 |
| 14 | Abnormality of magnesium homeostasis (HP:0004921) | 4.29513746 |
| 15 | * Metaphyseal cupping (HP:0003021) | 4.23050707 |
| 16 | Proximal tubulopathy (HP:0000114) | 4.14204161 |
| 17 | Abnormal drinking behavior (HP:0030082) | 3.98241029 |
| 18 | Polydipsia (HP:0001959) | 3.98241029 |
| 19 | Increased purine levels (HP:0004368) | 3.93944640 |
| 20 | Hyperuricemia (HP:0002149) | 3.93944640 |
| 21 | * Delayed epiphyseal ossification (HP:0002663) | 3.89462265 |
| 22 | Premature rupture of membranes (HP:0001788) | 3.81208147 |
| 23 | Abnormality of complement system (HP:0005339) | 3.79612057 |
| 24 | Abnormality of proline metabolism (HP:0010907) | 3.60558482 |
| 25 | Hydroxyprolinuria (HP:0003080) | 3.60558482 |
| 26 | Alkalosis (HP:0001948) | 3.57794254 |
| 27 | Neonatal short-limb short stature (HP:0008921) | 3.57369764 |
| 28 | Hyperglycinuria (HP:0003108) | 3.54603351 |
| 29 | Irregular epiphyses (HP:0010582) | 3.50387682 |
| 30 | Tetany (HP:0001281) | 3.46459940 |
| 31 | Abnormality of renin-angiotensin system (HP:0000847) | 3.44606957 |
| 32 | Abnormality of purine metabolism (HP:0004352) | 3.41316763 |
| 33 | Cupped ribs (HP:0000887) | 3.24530490 |
| 34 | Renal salt wasting (HP:0000127) | 3.22632536 |
| 35 | Small epiphyses (HP:0010585) | 3.22189887 |
| 36 | Vitreoretinal degeneration (HP:0000655) | 3.19666207 |
| 37 | Hyperaldosteronism (HP:0000859) | 3.16359163 |
| 38 | Flat acetabular roof (HP:0003180) | 3.13555379 |
| 39 | Metaphyseal irregularity (HP:0003025) | 3.11786593 |
| 40 | Generalized aminoaciduria (HP:0002909) | 3.11734797 |
| 41 | Enlarged epiphyses (HP:0010580) | 3.11649860 |
| 42 | * Hypercalciuria (HP:0002150) | 3.11032699 |
| 43 | Sudden death (HP:0001699) | 2.99636948 |
| 44 | Genu varum (HP:0002970) | 2.97408017 |
| 45 | Mild short stature (HP:0003502) | 2.97110909 |
| 46 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.90416863 |
| 47 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.84009303 |
| 48 | Abnormality of glycine metabolism (HP:0010895) | 2.84009303 |
| 49 | Hypokalemia (HP:0002900) | 2.81125739 |
| 50 | Ventricular tachycardia (HP:0004756) | 2.77474240 |
| 51 | Hypoplastic ischia (HP:0003175) | 2.72697460 |
| 52 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.71239019 |
| 53 | Protuberant abdomen (HP:0001538) | 2.69550662 |
| 54 | Adrenal overactivity (HP:0002717) | 2.69188212 |
| 55 | Abnormality of urine glucose concentration (HP:0011016) | 2.64168779 |
| 56 | Glycosuria (HP:0003076) | 2.64168779 |
| 57 | Atrioventricular block (HP:0001678) | 2.62653984 |
| 58 | * Abnormal tarsal ossification (HP:0008369) | 2.61968864 |
| 59 | Ketoacidosis (HP:0001993) | 2.59967722 |
| 60 | Soft skin (HP:0000977) | 2.59616194 |
| 61 | Systemic lupus erythematosus (HP:0002725) | 2.58907621 |
| 62 | Vascular calcification (HP:0004934) | 2.56515760 |
| 63 | Myokymia (HP:0002411) | 2.53422518 |
| 64 | Atrial fibrillation (HP:0005110) | 2.52851121 |
| 65 | Shallow orbits (HP:0000586) | 2.50740947 |
| 66 | Coxa vara (HP:0002812) | 2.49533209 |
| 67 | Heart block (HP:0012722) | 2.47967993 |
| 68 | Flat capital femoral epiphysis (HP:0003370) | 2.47950974 |
| 69 | Renal tubular acidosis (HP:0001947) | 2.46012082 |
| 70 | Glomerulosclerosis (HP:0000096) | 2.44160025 |
| 71 | Abnormality of the ischium (HP:0003174) | 2.43561490 |
| 72 | Rickets (HP:0002748) | 2.43269305 |
| 73 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.42324335 |
| 74 | Abnormality of nucleobase metabolism (HP:0010932) | 2.42088518 |
| 75 | Abnormality of the vertebral endplates (HP:0005106) | 2.41798171 |
| 76 | Turricephaly (HP:0000262) | 2.40879724 |
| 77 | Cardiovascular calcification (HP:0011915) | 2.40544200 |
| 78 | Abnormal atrioventricular conduction (HP:0005150) | 2.40428226 |
| 79 | Hyperlipoproteinemia (HP:0010980) | 2.40091311 |
| 80 | Abnormal vertebral ossification (HP:0100569) | 2.39449614 |
| 81 | Aortic dissection (HP:0002647) | 2.38895851 |
| 82 | Focal segmental glomerulosclerosis (HP:0000097) | 2.38870258 |
| 83 | Osteoarthritis (HP:0002758) | 2.36728390 |
| 84 | Widely patent fontanelles and sutures (HP:0004492) | 2.36325974 |
| 85 | Ketosis (HP:0001946) | 2.36124240 |
| 86 | Cervical subluxation (HP:0003308) | 2.35537855 |
| 87 | Bundle branch block (HP:0011710) | 2.34570515 |
| 88 | Enlarged kidneys (HP:0000105) | 2.32853499 |
| 89 | Irregular vertebral endplates (HP:0003301) | 2.30165361 |
| 90 | Broad metatarsal (HP:0001783) | 2.26826393 |
| 91 | Primary atrial arrhythmia (HP:0001692) | 2.26488424 |
| 92 | * Platyspondyly (HP:0000926) | 2.26108940 |
| 93 | Coronal craniosynostosis (HP:0004440) | 2.26013074 |
| 94 | Abnormality of potassium homeostasis (HP:0011042) | 2.24712665 |
| 95 | Short femoral neck (HP:0100864) | 2.23808373 |
| 96 | Nephrolithiasis (HP:0000787) | 2.23768536 |
| 97 | Muscle fiber splitting (HP:0003555) | 2.23538953 |
| 98 | Tubular atrophy (HP:0000092) | 2.23275994 |
| 99 | Supraventricular tachycardia (HP:0004755) | 2.20981100 |
| 100 | Supraventricular arrhythmia (HP:0005115) | 2.19363158 |
| 101 | Right ventricular cardiomyopathy (HP:0011663) | 2.18403190 |
| 102 | Carpal bone hypoplasia (HP:0001498) | 2.17753791 |
| 103 | Fragile skin (HP:0001030) | 2.17077597 |
| 104 | Syncope (HP:0001279) | 2.15646413 |
| 105 | * Metaphyseal dysplasia (HP:0100255) | 2.15124744 |
| 106 | Ovoid vertebral bodies (HP:0003300) | 2.14651409 |
| 107 | Wide anterior fontanel (HP:0000260) | 2.14427266 |
| 108 | Chondrocalcinosis (HP:0000934) | 2.14062189 |
| 109 | Bladder diverticulum (HP:0000015) | 2.13814172 |
| 110 | Delayed CNS myelination (HP:0002188) | 2.12531850 |
| 111 | Vascular tortuosity (HP:0004948) | 2.12414919 |
| 112 | Abnormality involving the epiphyses of the lower limbs (HP:0006500) | 2.10447084 |
| 113 | Abnormality of femoral epiphyses (HP:0006499) | 2.10447084 |
| 114 | Abnormality of the costochondral junction (HP:0000919) | 2.08854628 |
| 115 | Glomerulonephritis (HP:0000099) | 2.08269951 |
| 116 | Type 1 muscle fiber predominance (HP:0003803) | 2.07974306 |
| 117 | * Nephrocalcinosis (HP:0000121) | 2.07516228 |
| 118 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.05787036 |
| 119 | * Abnormality of carpal bone ossification (HP:0006257) | 2.05121359 |
| 120 | Aortic aneurysm (HP:0004942) | 2.04568929 |
| 121 | Abnormality of Sharpey fibers (HP:0100685) | 2.04380285 |
| 122 | Lipoatrophy (HP:0100578) | 2.03510056 |
| 123 | Protrusio acetabuli (HP:0003179) | 2.03235001 |
| 124 | Mitral valve prolapse (HP:0001634) | 2.02814680 |
| 125 | Hyperglycinemia (HP:0002154) | 2.02660950 |
| 126 | Beaking of vertebral bodies (HP:0004568) | 2.02066977 |
| 127 | Cerebral aneurysm (HP:0004944) | 2.01575061 |
| 128 | Hepatoblastoma (HP:0002884) | 1.98524915 |
| 129 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.98299277 |
| 130 | Xanthomatosis (HP:0000991) | 1.98295721 |
| 131 | Infantile muscular hypotonia (HP:0008947) | 1.97963229 |
| 132 | Deep venous thrombosis (HP:0002625) | 1.97888156 |
| 133 | Hyporeflexia of lower limbs (HP:0002600) | 1.96970476 |
| 134 | Ectopia lentis (HP:0001083) | 1.96923754 |
| 135 | Malnutrition (HP:0004395) | 1.96513974 |
| 136 | Hypoalphalipoproteinemia (HP:0003233) | 1.95956750 |
| 137 | Neonatal onset (HP:0003623) | 1.95627893 |
| 138 | Abnormality of the epiphysis of the femoral head (HP:0010574) | 1.95587469 |
| 139 | Bell-shaped thorax (HP:0001591) | 1.94868101 |
| 140 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 1.94507617 |
| 141 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.94237200 |
| 142 | Flattened epiphyses (HP:0003071) | 1.94083573 |
| 143 | Increased variability in muscle fiber diameter (HP:0003557) | 1.93372811 |
| 144 | Potter facies (HP:0002009) | 1.93199022 |
| 145 | Facial shape deformation (HP:0011334) | 1.93199022 |
| 146 | * Hypophosphatemia (HP:0002148) | 1.93056930 |
| 147 | Hypoplasia of the odontoid process (HP:0003311) | 1.92445662 |
| 148 | Spinal cord compression (HP:0002176) | 1.88950366 |
| 149 | Disproportionate short-trunk short stature (HP:0003521) | 1.88483573 |
| 150 | Patent foramen ovale (HP:0001655) | 1.88412223 |
| 151 | * Lymphangioma (HP:0100764) | 1.86054219 |
| 152 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.85576574 |
| 153 | Aplasia of the phalanges of the hand (HP:0009802) | 1.85576574 |
| 154 | Aplasia involving bones of the extremities (HP:0009825) | 1.85576574 |
| 155 | Atrophic scars (HP:0001075) | 1.85436343 |
| 156 | Ventricular arrhythmia (HP:0004308) | 1.84626972 |
| 157 | Prolonged partial thromboplastin time (HP:0003645) | 1.84017920 |
| 158 | Mitral stenosis (HP:0001718) | 1.83649347 |
| 159 | Action tremor (HP:0002345) | 1.82462662 |
| 160 | Arterial tortuosity (HP:0005116) | 1.81894054 |
| 161 | Thin ribs (HP:0000883) | 1.79358131 |
| 162 | Nephritis (HP:0000123) | 1.77628493 |
| 163 | Prolonged QT interval (HP:0001657) | 1.74694123 |
| 164 | Hyperextensible skin (HP:0000974) | 1.74653653 |
| 165 | Generalized muscle weakness (HP:0003324) | 1.72874160 |
| 166 | Ulnar bowing (HP:0003031) | 1.72310410 |
| 167 | Joint hemorrhage (HP:0005261) | 1.72119769 |
| 168 | Asymmetric septal hypertrophy (HP:0001670) | 1.68887356 |
| 169 | Round ear (HP:0100830) | 1.67352770 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WNK4 | 8.84313641 |
| 2 | OXSR1 | 6.44285346 |
| 3 | WNK3 | 5.99557206 |
| 4 | STK39 | 4.49915908 |
| 5 | STK38L | 3.78323876 |
| 6 | BCKDK | 2.73908522 |
| 7 | DDR2 | 2.61599793 |
| 8 | NTRK3 | 2.19902902 |
| 9 | EPHA4 | 2.13023718 |
| 10 | PAK6 | 1.78212068 |
| 11 | TRIB3 | 1.75905478 |
| 12 | EPHB2 | 1.75666331 |
| 13 | DMPK | 1.70087811 |
| 14 | WNK1 | 1.69156087 |
| 15 | NTRK2 | 1.64004955 |
| 16 | LATS1 | 1.63083911 |
| 17 | MAP3K3 | 1.59134554 |
| 18 | NEK1 | 1.55533832 |
| 19 | TIE1 | 1.47892585 |
| 20 | MARK1 | 1.46727180 |
| 21 | LMTK2 | 1.43372701 |
| 22 | PDK2 | 1.40744914 |
| 23 | PDK3 | 1.38853568 |
| 24 | PDK4 | 1.38853568 |
| 25 | UHMK1 | 1.37688207 |
| 26 | FGFR2 | 1.31436079 |
| 27 | CAMK1 | 1.30638936 |
| 28 | SGK223 | 1.27886447 |
| 29 | SGK494 | 1.27886447 |
| 30 | AKT3 | 1.25162820 |
| 31 | MYLK | 1.24594460 |
| 32 | PAK4 | 1.24547974 |
| 33 | FGFR4 | 1.23745184 |
| 34 | OBSCN | 1.19409751 |
| 35 | DAPK2 | 1.19099603 |
| 36 | MARK2 | 1.13799894 |
| 37 | SIK1 | 1.11596402 |
| 38 | STK38 | 1.10736479 |
| 39 | MST4 | 1.06823316 |
| 40 | TGFBR2 | 1.06819678 |
| 41 | LATS2 | 1.05221399 |
| 42 | PHKG1 | 1.03179868 |
| 43 | PHKG2 | 1.03179868 |
| 44 | TESK1 | 0.98960488 |
| 45 | LRRK2 | 0.96980552 |
| 46 | CDC42BPA | 0.96593978 |
| 47 | PRKG2 | 0.94802865 |
| 48 | PDGFRA | 0.94543108 |
| 49 | ARAF | 0.94300754 |
| 50 | PRPF4B | 0.90380328 |
| 51 | MAP3K6 | 0.89931524 |
| 52 | GSK3A | 0.88225965 |
| 53 | GRK5 | 0.86605100 |
| 54 | CAMKK1 | 0.86402951 |
| 55 | DAPK3 | 0.84224577 |
| 56 | TYRO3 | 0.83465500 |
| 57 | ICK | 0.82109686 |
| 58 | NME1 | 0.77586637 |
| 59 | TGFBR1 | 0.77431062 |
| 60 | PTK6 | 0.76736664 |
| 61 | CAMK2B | 0.75800199 |
| 62 | CAMK2G | 0.74289624 |
| 63 | PTK2 | 0.74203537 |
| 64 | MST1R | 0.73307670 |
| 65 | PKN2 | 0.71012149 |
| 66 | MAPK7 | 0.70344470 |
| 67 | FER | 0.70004674 |
| 68 | SGK3 | 0.67977707 |
| 69 | CDK5 | 0.67020463 |
| 70 | RET | 0.66650422 |
| 71 | CAMK2D | 0.66193722 |
| 72 | STK24 | 0.64794808 |
| 73 | ROCK1 | 0.63505938 |
| 74 | EPHB1 | 0.61472169 |
| 75 | RIPK1 | 0.61372430 |
| 76 | PAK3 | 0.60740663 |
| 77 | CAMK2A | 0.60122305 |
| 78 | SGK2 | 0.59700216 |
| 79 | EEF2K | 0.59419711 |
| 80 | ERN1 | 0.59088758 |
| 81 | MAP3K7 | 0.58909996 |
| 82 | MINK1 | 0.57313975 |
| 83 | PIK3CA | 0.57214949 |
| 84 | MAP2K3 | 0.56695410 |
| 85 | ABL2 | 0.56608580 |
| 86 | STK3 | 0.56020115 |
| 87 | MUSK | 0.55071092 |
| 88 | PTK2B | 0.54688488 |
| 89 | DYRK1B | 0.54467216 |
| 90 | KDR | 0.53149061 |
| 91 | MAPK10 | 0.52932892 |
| 92 | MET | 0.52813023 |
| 93 | KSR2 | 0.49656562 |
| 94 | RPS6KA2 | 0.47424180 |
| 95 | PRKCI | 0.44991007 |
| 96 | NME2 | 0.43792602 |
| 97 | FLT3 | 0.42617881 |
| 98 | TAOK1 | 0.42267828 |
| 99 | RPS6KA3 | 0.42091762 |
| 100 | PRKCG | 0.41848249 |
| 101 | PINK1 | 0.41212351 |
| 102 | NEK9 | 0.40639286 |
| 103 | FGFR1 | 0.39487686 |
| 104 | SGK1 | 0.39130586 |
| 105 | PDPK1 | 0.37637488 |
| 106 | PRKAA1 | 0.37148062 |
| 107 | NTRK1 | 0.36148152 |
| 108 | PRKAA2 | 0.32196137 |
| 109 | PAK2 | 0.32084412 |
| 110 | MAPK12 | 0.31949285 |
| 111 | MAP3K11 | 0.29710187 |
| 112 | MTOR | 0.29208012 |
| 113 | MAPK11 | 0.28454093 |
| 114 | GRK6 | 0.26469141 |
| 115 | BMX | 0.25658504 |
| 116 | MAP2K1 | 0.22855210 |
| 117 | PRKCZ | 0.21302124 |
| 118 | PRKACG | 0.20657772 |
| 119 | AKT2 | 0.19682984 |
| 120 | PRKD2 | 0.17731604 |
| 121 | PRKD3 | 0.16966871 |
| 122 | MAP3K10 | 0.15277559 |
| 123 | IGF1R | 0.13742991 |
| 124 | ADRBK1 | 0.13385825 |
| 125 | PDK1 | 0.12817807 |
| 126 | PDGFRB | 0.12599906 |
| 127 | PRKCH | 0.11886330 |
| 128 | STK11 | 0.11723955 |
| 129 | KSR1 | 0.11270601 |
| 130 | INSR | 0.11219292 |
| 131 | SRC | 0.11045146 |
| 132 | STK10 | 0.10780723 |
| 133 | PRKACA | 0.09965024 |
| 134 | MAPK4 | 0.08331959 |
| 135 | PRKCD | 0.07882490 |
| 136 | ILK | 0.07770189 |
| 137 | TTN | 0.07304816 |
| 138 | PRKD1 | 0.07011353 |
| 139 | CAMK4 | 0.06826792 |
| 140 | ERBB2 | 0.06648171 |
| 141 | PRKCA | 0.06483211 |
| 142 | ROCK2 | 0.06006669 |
| 143 | PIM1 | 0.05792643 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.45467772 |
| 2 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.38820019 |
| 3 | Butanoate metabolism_Homo sapiens_hsa00650 | 3.23287327 |
| 4 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 3.10123459 |
| 5 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 3.09327311 |
| 6 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.09215112 |
| 7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.94233349 |
| 8 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.90124686 |
| 9 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.85666959 |
| 10 | Protein digestion and absorption_Homo sapiens_hsa04974 | 2.69207002 |
| 11 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.57661632 |
| 12 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.43286400 |
| 13 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.22857071 |
| 14 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.19460836 |
| 15 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.18371472 |
| 16 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.16281496 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 2.12882284 |
| 18 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.07698214 |
| 19 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.91058820 |
| 20 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.86397706 |
| 21 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.85769746 |
| 22 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.82864977 |
| 23 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.70800222 |
| 24 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.65332002 |
| 25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.64889324 |
| 26 | Prion diseases_Homo sapiens_hsa05020 | 1.64054695 |
| 27 | Bile secretion_Homo sapiens_hsa04976 | 1.60537170 |
| 28 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.58746776 |
| 29 | Carbon metabolism_Homo sapiens_hsa01200 | 1.57412807 |
| 30 | Lysine degradation_Homo sapiens_hsa00310 | 1.54537429 |
| 31 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.50290049 |
| 32 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.48326469 |
| 33 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.46826881 |
| 34 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.46588206 |
| 35 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.45768685 |
| 36 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.35971739 |
| 37 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.34782807 |
| 38 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.31290840 |
| 39 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.28229042 |
| 40 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.27256526 |
| 41 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.25725448 |
| 42 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.24281883 |
| 43 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.22137488 |
| 44 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.17140300 |
| 45 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.16129158 |
| 46 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.14658091 |
| 47 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.10880033 |
| 48 | Other glycan degradation_Homo sapiens_hsa00511 | 1.09776188 |
| 49 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.07289044 |
| 50 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.06973671 |
| 51 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.04935957 |
| 52 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.02771301 |
| 53 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.99900999 |
| 54 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.96893750 |
| 55 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.94740934 |
| 56 | * Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.92999687 |
| 57 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.92063355 |
| 58 | Focal adhesion_Homo sapiens_hsa04510 | 0.91172201 |
| 59 | Circadian entrainment_Homo sapiens_hsa04713 | 0.89853368 |
| 60 | Mineral absorption_Homo sapiens_hsa04978 | 0.89663495 |
| 61 | GABAergic synapse_Homo sapiens_hsa04727 | 0.87795156 |
| 62 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.87048434 |
| 63 | Insulin secretion_Homo sapiens_hsa04911 | 0.82829174 |
| 64 | Renin secretion_Homo sapiens_hsa04924 | 0.81323194 |
| 65 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.80959058 |
| 66 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.80272109 |
| 67 | Histidine metabolism_Homo sapiens_hsa00340 | 0.79533010 |
| 68 | Morphine addiction_Homo sapiens_hsa05032 | 0.79250338 |
| 69 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.79073426 |
| 70 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.77976118 |
| 71 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.73324740 |
| 72 | Long-term potentiation_Homo sapiens_hsa04720 | 0.71565755 |
| 73 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.70069708 |
| 74 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.68067259 |
| 75 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.67586905 |
| 76 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.67071286 |
| 77 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.66652948 |
| 78 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.66298382 |
| 79 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.65531366 |
| 80 | Melanogenesis_Homo sapiens_hsa04916 | 0.64911478 |
| 81 | Cocaine addiction_Homo sapiens_hsa05030 | 0.62905731 |
| 82 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.59606275 |
| 83 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.59214040 |
| 84 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.58541203 |
| 85 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.57825726 |
| 86 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.56823629 |
| 87 | Nicotine addiction_Homo sapiens_hsa05033 | 0.56738957 |
| 88 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.55371346 |
| 89 | Gap junction_Homo sapiens_hsa04540 | 0.52368513 |
| 90 | Tight junction_Homo sapiens_hsa04530 | 0.52124479 |
| 91 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.51039732 |
| 92 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.50071065 |
| 93 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.50068369 |
| 94 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.49851460 |
| 95 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.49805931 |
| 96 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.49366886 |
| 97 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.48506797 |
| 98 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.47734468 |
| 99 | Metabolic pathways_Homo sapiens_hsa01100 | 0.47057323 |
| 100 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.46559472 |
| 101 | Retinol metabolism_Homo sapiens_hsa00830 | 0.45163437 |
| 102 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.45061158 |
| 103 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.43496075 |
| 104 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.43355917 |
| 105 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.42412328 |
| 106 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.42329997 |
| 107 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.42150054 |
| 108 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.41937317 |
| 109 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.41011982 |
| 110 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.39658241 |
| 111 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.38391923 |
| 112 | Lysosome_Homo sapiens_hsa04142 | 0.36803751 |
| 113 | Bladder cancer_Homo sapiens_hsa05219 | 0.36775895 |
| 114 | Galactose metabolism_Homo sapiens_hsa00052 | 0.35693207 |
| 115 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.35390508 |
| 116 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.35388642 |
| 117 | Amoebiasis_Homo sapiens_hsa05146 | 0.34336327 |
| 118 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.33657179 |
| 119 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.32327598 |
| 120 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.32176985 |
| 121 | Sulfur relay system_Homo sapiens_hsa04122 | 0.29644021 |
| 122 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.29330183 |
| 123 | Insulin resistance_Homo sapiens_hsa04931 | 0.24523839 |
| 124 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.24385757 |
| 125 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.24122812 |
| 126 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.23732143 |
| 127 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.23382018 |
| 128 | Parkinsons disease_Homo sapiens_hsa05012 | 0.23260643 |
| 129 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.21902376 |
| 130 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.21173655 |
| 131 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.19836002 |
| 132 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.16443226 |
| 133 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.15274295 |
| 134 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.14212910 |
| 135 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.12659878 |
| 136 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.12605632 |
| 137 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.11785630 |
| 138 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.11707934 |
| 139 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.11221290 |
| 140 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.07949987 |

